In terms of Regulation 47 read with Schedule III Part A Para A of SEBI LODR Regulations, 2015, please find attached herewith the newspaper advertisement for the audited financial results ....
BAYERCROP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bayer CropScience has published its audited financial results for the full year ended March 31, 2025, in four newspapers (Financial Express, Loksatta, Free Press Journal, Navshakti) as required by SEBI listing rules. For FY25, total income from operations rose to ₹54,734 million from ₹51,062 million in FY24, a growth of about 7%. However, profit after tax declined sharply to ₹5,680 million from ₹7,405 million in FY24, a drop of roughly 23%. Basic EPS also fell from ₹164.77 to ₹126.38 over the same period. On a quarterly basis, Q4 FY25 showed a strong recovery with PAT of ₹1,433 million (vs ₹960 million in Q4 FY24, up ~49%) and revenue of ₹10,464 million (vs ₹7,923 million, up ~32%), though PBT for the full year still came in lower at ₹7,074 million vs ₹9,414 million.
Despite top-line growth, the sharp drop in full-year profits and EPS may weigh on investor sentiment. The strong Q4 rebound suggests a recovery in momentum, but the FY profit decline could limit near-term upside.